TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden

European Journal of Human Genetics

Volumn 15, Issue 3, 2007, Pages 342-346

  Mayans, Sofia ^a   Lackovic, Kurt ^a   Lindgren, Petter ^a   Ruikka, Karin ^b   Ågren, Åsa ^a   Eliasson, Mats ^a,b   Holmberg, Dan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR 7 LIKE 2 PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TCF TRANSCRIPTION FACTORS;

EID: 33847211808     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201773     Document Type: Article

References (23)

1. Malecki MT: Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 68 (Suppl 1): S10-S21.
2. Parikh H, Groop L: Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 2004; 5: 151-176.
3. Hanis CL, Boerwinkle E, Chakraborty R et al: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166.
4. Mahtani MM, Widen E, Lehto M et al: Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996; 14: 90-94.
5. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ: A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 1999; 48: 1175-1182.
6. Horikawa Y, Oda N, Cox NJ et al: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
7. Grant SF, Thorleifsson G, Reynisdottir I et al: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323.
8. Altshuler D, Hirschhorn JN, Klannemark M et al: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
9. Hani EH, Boutin P, Durand E et al: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 1998; 41: 1511-1515.
10. Gloyn AL, Weedon MN, Owen KR et al: Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23 K variant is associated with type 2 diabetes. Diabetes 2003; 52: 568-572.
11. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC: Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). Diabet Med 2001; 18: 206-212.
12. Einarsdottir E, Mayans S, Ruikka K et al: Linkage but not association of calpain-10 to type 2 diabetes replicated in northern Sweden. Diabetes 2006; 55: 1879-1883.
13. Florez JC, Jablonski KA, Bayley N et al: TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355: 241-250.
14. WHO: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO consultation. Geneva: World Health Organization, 1999; 1-59.
15. BarreAt JC, Fry B, Mailer J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
16. Clayton D: A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
17. Huber P: The behaviour of maximum likelihood estimates under nonstandard conditions: Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability. Berkeley: University of California Press, 1967; 1: Pp. 221-233.
18. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
19. Cauchi S, Meyre D, Choquet H et al: TCF7L2 variation predicts hyperglycemia incidence in a French general population: The data from an epidemiological study on the insulin resistance syndrome (DESIR) study. Diabetes 2006; 55: 3189-3192.
20. Cauchi S, Meyre D, Dina C et al: Transcription factor TCF7L2 genetic study in the French population: Expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006; 55: 2903-2908.
21. Saxena R, Gianniny L, Burtt NP et al: Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006; 55: 2890-2895.
22. Damcott CM, Pollin TI, Reinhart LJ et al: Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: Replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006; 55: 2654-2659.
23. Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005; 280: 1457-1464.